← Back
$GRTX All transactions

Galera Therapeutics, Inc.

C

$ Value

Shares

5,336,870

Price

Filed

Apr 9

Insider

Name

FRIEDMAN MICHAEL R.

Title

CIK

0001993243

Roles

Director

Transaction Details

Transaction Date

2026-04-07

Code

C

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

5,336,870

Footnotes

On February 12, 2026, the Issuer filed a Certificate of Amendment (the "Amendment") to the Certificate of Designation of Preferences, Rights, and Limitations of Series B Non-Voting Convertible Preferred Stock. The Amendment provided that, in the sole discretion of the Issuer's board of directors, the Issuer may elect to convert, in whole or in part, outstanding shares of Series B Non-Voting Convertible Preferred Stock ("Series B Preferred Stock") into a number of shares of Common Stock calculated based on the Conversion Ratio (defined as 1,000 shares of Common Stock issuable upon the conversion of each share of Series B Preferred Stock) (a "Mandatory Conversion"). On April 7, 2026, the Issuer effected a partial Mandatory Conversion of Series B Preferred Stock, including shares of Series B Preferred Stock held by the Reporting Person. The shares of Series B Preferred Stock have no expiration date. | These securities are held by Equity Trust Company, Custodian FBO Michael Friedman Roth IRA.

Filing Info

Accession No.

0000905148-26-001623

Form Type

4

Issuer CIK

0001563577

FRIEDMAN MICHAEL R.'s History

Date Ticker Type Value
2026-04-07 GRTX C
2026-04-07 GRTX C $0

Other Insiders at GRTX (90d)

Insider Bought Sold Last
CHANG NANCY T 2026-04-07
FRIEDMAN MICHAEL R. 2026-04-07